1. Visfatin and its genetic variants are associated with obesity‐related morbidities and cardiometabolic risk in severely obese children. Issue 2 (28th February 2013) Authors: Ooi, S. Q.; Chan, R. M. E.; Poh, L. K. S.; Loke, K. Y.; Heng, C. K.; Chan, Y. H.; Gan, S. U.; Lee, K. O.; Lee, Y. S. Journal: Pediatric obesity Issue: Volume 9:Issue 2(2014:Apr.) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗